Alan C. Moss, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Alan Moss, MD, FACG, AGAF, FEBG, FRCPI is a clinician-scientist with an interest in Crohn's disease and Ulcerative Colitis (Inflammatory Bowel Disease, IBD). His clinical expertise is in management of IBD, and he is Director of the Crohn's & Colitis Program at Boston Medical Center. His research interests include microbial therapeutics, mucosal immunology and clinical outcomes. He has held grant funding from NIDDK, AGA, Helmsley Charitable Trust, and the Crohn's & Colitis Foundation. He has published over 120 research papers (h-index 28), including many cited in national and international practice guidelines. Dr Moss has held positions as Deputy-Editor of Crohn's & Colitis 360, and as Associate Editor for Journal of Crohn’s & Colitis (ECCO), Frontline Gastroenterology (BMJ) and the World Journal of Gastroenterology. He has served on the Nominating Committee of the IBD section of AGA, and the Professional Education and National Scientific Advisory Committee for the Crohn's & Colitis Foundation. He is a reviewer for national and international research bodies, including the NIDDK and European Research Council.

Publications

  • Published 5/23/2024

    Allegretti JR, Bordeianou LG, Damas OM, Eisenstein S, Greywoode R, Minar P, Singh S, Harmon S, Lisansky E, Malone-King M, Litwin NS, Weaver A, Heller CA, Moss AC, Adler J. Challenges in IBD Research 2024: Pragmatic Clinical Research. Inflamm Bowel Dis. 2024 May 23; 30(Supplement_2):S55-S66. PMID: 38778623.

    Read at: PubMed

  • Published 5/23/2024

    Prasad S, Cross RK, Monroe MB, Dolinger MT, Motte R, Hong S, Stidham RW, Kumar N, Levine D, Larijani A, Simone A, Chachu KA, Wyborski R, Heller CA, Moss AC, Schwerbrock NMJ, Selaru FM. Challenges in IBD Research 2024: Novel Technologies. Inflamm Bowel Dis. 2024 May 23; 30(Supplement_2):S30-S38. PMID: 38778625.

    Read at: PubMed

  • Published 5/23/2024

    Heller C, Moss AC, Rubin DT. Overview to Challenges in IBD 2024-2029. Inflamm Bowel Dis. 2024 May 23; 30(Supplement_2):S1-S4. PMID: 38778626.

    Read at: PubMed

  • Published 5/23/2024

    Ciorba MA, Konnikova L, Hirota SA, Lucchetta EM, Turner JR, Slavin A, Johnson K, Condray CD, Hong S, Cressall BK, Pizarro TT, Hurtado-Lorenzo A, Heller CA, Moss AC, Swantek JL, Garrett WS. Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms. Inflamm Bowel Dis. 2024 May 23; 30(Supplement_2):S5-S18. PMID: 38778627.

    Read at: PubMed

  • Published 3/26/2024

    Attree C, Ogra R, Yusoff IF, Moss AC, Jacques A, Brown G, Alexander S, Efthymiou M, Raftopoulos S. Hot avulsion versus argon plasma coagulation for the management of the non-ensnarable polyp: A multicenter, randomized controlled trial. JGH Open. 2024 Mar; 8(3):e13052. PMID: 38533237.

    Read at: PubMed

View All 164 Publications:   View Full Profile in BUMC

Websites

View all profiles